MEG
MLAB icon

Millstone Evans Group’s Mesa Laboratories MLAB Stock Holding History

Millstone Evans Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Hold
120
– – 0.01% 569
2026
Q1 		$10.6K Buy
+120
New +$10.3K 0.01% 565
2025
Q2 		– Sell
-40
Closed -$4.75K – 804
2025
Q1 		$4.75K Buy
+40
New +$5.45K ﹤0.01% 610

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millstone Evans Group's MLAB Position: Q2 2026 in Review

Millstone Evans Group held its Mesa Laboratories (MLAB) position steady in Q2 2026 at 120 shares worth $11.9K. The position accounts for 0.01% of the portfolio, ranked #569.

Millstone Evans Group first reported a position in MLAB in Q1 2025 and has held it in 3 quarters since. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Millstone Evans Group held 120 shares of Mesa Laboratories worth $11.9K as of Q2 2026.
  • Millstone Evans Group left its Mesa Laboratories share count unchanged in Q2 2026.
  • Mesa Laboratories made up 0.01% of Millstone Evans Group's portfolio in Q2 2026, its #569 holding.
  • Millstone Evans Group first reported a position in Mesa Laboratories in Q1 2025 and has held it in 3 quarters since.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.